TIGIT and neoplasm: Of note, mice treated with VV-α-TIGIT exhibited approximately 70% (10/14) of tumor complete regression (CR), whereas mice treated with VV-Control only showed approximately 30% (4/14) of tumor CR, and mice treated with PBS was not observed with tumor CR (Fig. 6G).